Cullinan Therapeutics, Inc. CGEM Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s investment purchases?
- Cullinan Therapeutics, Inc. (CGEM) reported investment purchases of $20.14M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s investment purchases changed year-over-year?
- Cullinan Therapeutics, Inc.'s investment purchases decreased by 84.0% year-over-year, from $125.84M to $20.14M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s investment purchases?
- Over 4 years (2021 to 2025), Cullinan Therapeutics, Inc.'s investment purchases has grown at a -18.1% compound annual growth rate (CAGR), from $525.81M to $236.53M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.